LLGL1 Antikörper
Kurzübersicht für LLGL1 Antikörper (ABIN7002976)
Target
Alle LLGL1 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Produktmerkmale
- Polyclonal Antibody
-
Aufreinigung
- Affinity purification
-
Immunogen
- Synthetic peptide of human LLGL1
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
- WB 1:500-1:2000
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- 0.6 mg/mL
-
Buffer
- PBS with 0.05 % sodium azide and 50 % glycerol, PH7.4
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- Store at -20°C. Avoid freeze / thaw cycles.
-
-
- LLGL1 (Lethal Giant Larvae Homolog 1 (LLGL1))
-
Andere Bezeichnung
- LLGL1
-
Hintergrund
- This gene encodes a protein that is similar to a tumor suppressor in Drosophila. The protein is part of a cytoskeletal network and is associated with nonmuscle myosin II heavy chain and a kinase that specifically phosphorylates this protein at serine residues. The gene is located within the Smith-Magenis syndrome region on chromosome 17.
-
Molekulargewicht
- 115 kDa
-
NCBI Accession
- NP_004131
-
UniProt
- Q15334
-
Pathways
- WNT Signalweg
Target
-